Zepp Health Corporation (ZEPP)
NYSE:ZEPP
Want to see ZEPP full AI Analyst Report?
ZEPP Stock Chart & Stats
$16.76
$0.05(1.72%)
At close: 4:00 PM EST
$16.76
$0.05(1.72%)
Day’s Range― - ―
52-Week Range$2.25 - $61.85
Previous CloseN/A
Volume1.93K
Average Volume (3M)88.56K
Market Cap
$126.54M
Enterprise Value$1.64B
Total Cash (Recent Filing)$789.70M
Total Debt (Recent Filing)$1.59B
Price to Earnings (P/E)―
Beta0.90
Next Earnings
May 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-90.67
Shares Outstanding8,460,126
10 Day Avg. Volume155,748
30 Day Avg. Volume88,562
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.12
Price to Sales (P/S)0.10
P/FCF Ratio-7.07
Enterprise Value/Market Cap12.99
Enterprise Value/Revenue0.89
Enterprise Value/Gross Profit2.32
Enterprise Value/Ebitda-8.79
Forecast
1Y Price Target
$56.28Price Target Upside235.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.01
Revenue Forecast (FY)$309.92M
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth & Product MomentumSustained, high double-digit top-line growth demonstrates recovering demand and successful product cycles. Management cites new premium SKUs and Q1 guidance of +30%–+43% YoY, indicating this revenue momentum may persist and support scaling operating leverage over coming quarters.
Sustained Gross-margin ExpansionMaterial margin improvement from ~19% in 2022 to ~38% in 2025 reflects durable product premiumization and maintained price integrity. Higher ASPs and favorable mix are structural levers that can sustain margins even as volumes scale, improving long-term profitability potential.
Improving Liquidity And Working-capital TrendsA meaningful cash buffer combined with lower inventory and executed debt retirements increases financial flexibility. Improved working capital reduces rollover risk and supports continued R&D, marketing and targeted buybacks without immediate reliance on new external financing.
Bears Say
Ongoing GAAP Losses & Negative Cash FlowPersistent GAAP losses and recent negative operating/free cash flow indicate the company has not yet re-established self-sustaining profitability. Continued losses can force reliance on balance-sheet support, constrain reinvestment, and increase refinancing or dilution risk if margins or growth falter.
Rising Leverage; Debt Slightly Above EquityA rising debt-to-equity ratio reduces financial flexibility and increases interest and refinancing exposure. If cyclical pressures or input-cost shocks recur, higher leverage could limit the firm's ability to invest in product development or channel growth without compromising liquidity.
Supply Constraints And Input-cost HeadwindsManufacturing shortfalls and rising component costs can cap sell-through, elevate unit costs, and disrupt planned premiumization. These operational and procurement risks are structural enough to affect margins and revenue consistency until capacity and BOM cost pressures are fully resolved.
Zepp Health News
ZEPP FAQ
What was Zepp Health Corporation’s price range in the past 12 months?
Zepp Health Corporation lowest stock price was $2.25 and its highest was $61.85 in the past 12 months.
What is Zepp Health Corporation’s market cap?
Zepp Health Corporation’s market cap is $126.54M.
When is Zepp Health Corporation’s upcoming earnings report date?
Zepp Health Corporation’s upcoming earnings report date is May 26, 2026 which is tomorrow.
How were Zepp Health Corporation’s earnings last quarter?
Zepp Health Corporation released its earnings results on Mar 15, 2026. The company reported -$0.03 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.03.
Is Zepp Health Corporation overvalued?
According to Wall Street analysts Zepp Health Corporation’s price is currently Undervalued.
Does Zepp Health Corporation pay dividends?
Zepp Health Corporation pays a Notavailable dividend of $0.1 which represents an annual dividend yield of N/A. See more information on Zepp Health Corporation dividends here
What is Zepp Health Corporation’s EPS estimate?
Zepp Health Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zepp Health Corporation have?
Zepp Health Corporation has 8,460,126 shares outstanding.
What happened to Zepp Health Corporation’s price movement after its last earnings report?
Zepp Health Corporation reported an EPS of -$0.03 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.704%.
Which hedge fund is a major shareholder of Zepp Health Corporation?
Currently, no hedge funds are holding shares in ZEPP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Zepp Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$56.28 (235.80% Upside)
$56.28 (235.80% Upside)
Blogger Sentiment
Bullish
ZEPP Sentiment 70%
Sector Average ―
Sector Average ―
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 5.5%
Last 30 Days ▼ 5.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
238.03%
12-Months-Change
Fundamentals
Return on Equity
-17.94%
Trailing 12-Months
Asset Growth
6.86%
Trailing 12-Months
Company Description
Zepp Health Corporation
Zepp Health Corporation, together with its subsidiaries, develops, manufactures, and sells smart wearable technological devices in the People's Republic of China. It operates through two segments, Xiaomi Wearable Products, and Self-Branded Products and Others. The company offers smart bands, watches, and scales; and smart hearable products, home treadmill, sportswear, home appliances, and smart watch accessories under the Xiaomi and Amazfit brands. It provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.
ZEPP Company Deck
ZEPP Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a broadly positive operational turnaround: strong revenue growth (41.8% FY, 43% Q4), a record gross margin (~40.4%) driven by premiumization, improved adjusted losses and solid cash balances. Management acknowledged near-term headwinds—one-time provisions, higher operating spend tied to strategic brand and channel investments, memory cost pressure, and some SKU supply shortages—but characterized many cost increases as non-structural and reiterated confidence in continued margin expansion and strong 2026 demand (Q1 guide +30% to +43% YoY). On balance, the favorable top-line, margin expansion and improving profitability trends outweigh the manageable lowlights highlighted by management.View all ZEPP earnings summariesZEPP Stock 12 Month Forecast
Average Price Target
$56.28
▲(235.80% Upside)
Technical Analysis
Ownership Overview
―
Insiders
3.83% Mutual Funds
3.10% Other Institutional Investors
91.20% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---